We scan new podcasts and send you the top 5 insights daily.
Engineering teams often default to hand-sewn stent covers in early phases because manual suturing is readily accessible and can be performed in-house. This initial convenience biases downstream architecture, committing programs to design constraints based on early prototyping ease rather than clinical optimization.
Engineers often finalize a bare metal scaffold before addressing its covering, expecting the membrane to not affect radial strength or crimp profile. However, a covered stent behaves as a composite material where the scaffold, polymer, and vessel properties interact and must be designed simultaneously.
Synchrony Medical discovered a major flaw in their vest not in a lab, but by watching people try to put it on themselves. Observing this unassisted, real-world task revealed the air tubes were a tripping hazard, prompting a crucial redesign that would have been costly to fix later.
When developing a medical device, the manufacturing process for the very first prototype should be designed with scalability in mind. If the process is unsolvable at a thousand-unit scale, the product concept itself is likely unviable and needs reconsideration from the earliest stages.
Experts often design components in isolation, perfecting their specific 'Lego' piece. When it's time to assemble the final device, these pieces fail to fit together because a systems-level approach was missing from the start, leading to costly rework and integration challenges.
Catheter assembly remains a surprisingly manual process because experienced operators develop a tactile sense for applying the right amount of force and making subtle adjustments. This 'touchy-feely' expertise, which varies from part to part, is difficult and often financially impractical to replicate with robotic automation.
Because chronic animal studies are costly and slow, engineering teams frequently receive in vivo data very late in product development. Consequently, issues like unexpected thrombosis or density mismatches are uncovered just prior to clinical trials, forcing abrupt redesigns between product generations.
For hardware startups on a tight budget, investing more time upfront in documentation—defining problem statements, user needs, and design inputs—and detailed CAD significantly reduces the number of expensive physical prototype cycles. This disciplined approach maximizes a limited budget for greater success.
Instead of waiting for sophisticated 3D prints, an engineer used duct tape and plastic scraps to create a proof-of-concept. This crude but functional prototype not only worked but also impressed the client. It demonstrates that the goal is rapid learning, not polished hardware, in the early stages.
Technologically superior products often fail because they disrupt clinical workflows. To succeed, companies must integrate workflow considerations from the very beginning of the design process, viewing the product as a complete solution, not just an engineering project.
Joseph Hirsch details that medical device R&D is highly iterative. Beyond CAD and mechanical testing, Medtronic relies heavily on feedback from surgeons who test prototypes in cadaver labs. This direct, hands-on input is critical for refining designs before seeking FDA approval.